Shoukhrat Mitalipov, Ph.D., and the Center for Embryonic Cell and Gene Therapy are included in a Medium article summarizing “The 7 Craziest Ways CRISPR is Being Used Right Now.”
Comment from David Barnard, Ph.D., J.D., is included in an article about the trend of Death Café’s, a community tactic used to normalize end of life planning processes
A systematic review conducted by Amy Cantor M.D., M.P.H., on behalf of the U.S. Preventive Services Task Force, determined lack of evidence in assessment of elevated blood lead levels in childhood and during pregnancy.
The announcement of the clinical trial data for stage II-IIIA melanoma, Sancy Leachman, M.D., Ph.D., says: “Optimization of adjuvant clinical trial enrollment for melanoma is increasingly important given the adverse effects that are associated with current targeted and immune checkpoint therapies.”